ITGSS Certified Technical Associate: Emerging Tech Practice Test

Minimally invasive treatments of liver tumors have:

1. Not proven to be effective

2. Been only used in trials

3. Exceeded those obtained with conventional chemotherapy or radiation

4. Not exceeded those obtained with conventional chemotherapy or radiation

The correct answer is: Exceeded those obtained with conventional chemotherapy or radiation

Minimally invasive treatments of liver tumors, such as radiofrequency ablation (RFA), microwave ablation (MWA), and transarterial radioembolization (TARE), are designed to target tumors directly while minimizing damage to surrounding healthy tissues. These techniques have shown promising results in clinical studies, often delivering better outcomes than conventional therapies like chemotherapy or radiation in certain cases. The advancements in imaging guidance and techniques have improved the precision of these interventions, leading to higher rates of tumor control and potentially better overall survival rates for patients. By allowing for a quicker recovery, fewer side effects, and reduced hospital stays, these methods offer advantages that make them increasingly effective in treating liver tumors compared to traditional treatments. Factors such as the patient's overall health, the size and location of the tumor, and specific tumor characteristics can influence the success rates, but the general trend observed in the medical literature indicates that these minimally invasive approaches frequently outperform conventional methods of treatment for liver tumors in selected patient populations.